Search

everythinglearnresearchcommunity

for

Search:↓

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.

Higher hs-CRP levels in Indian adolescent women with PCOS are more related to BMI than PCOS itself.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Spironolactone may help reduce hair loss in androgenic alopecia.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

The document concludes that PCOS has a strong genetic component, but more research is needed to fully understand the specific genes involved.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Canine epidermal neural crest stem cells could be a promising treatment for spinal cord injuries in dogs.

EGFR inhibitors can cause yellowish skin eruptions.

Taking metformin with intense-pulsed-light therapy improves hair removal for people with PCOS.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Cimetidine did not reduce hair growth in women with hirsutism.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

FPHL is common in women, influenced by genetics and hormones, and can be treated with medications, laser therapy, or hair transplantation.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.

Eating a balanced diet with specific nutrients is important for menopausal women to manage hair loss.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.